Beijing Strong Biotechnologies,Inc. (SHE:300406)

Market Cap	6.85B -17.6%
Revenue (ttm)	1.37B -9.3%
Net Income	224.95M -51.4%
EPS	0.38 -51.0%
Shares Out	584.78M
PE Ratio	30.92
Forward PE	16.51
Dividend	0.70 (5.97%)
Ex-Dividend Date	Sep 3, 2026

Volume	5,314,100
Open	11.73
Previous Close	11.72
Day's Range	11.64 - 11.86
52-Week Range	10.52 - 16.05
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About SHE:300406

Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. It provides biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein S activity, protein C, lu...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2001
• Employees: 998
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300406

Financial Performance

In 2025, SHE:300406's revenue was 1.36 billion, a decrease of -18.29% compared to the previous year's 1.66 billion. Earnings were 189.87 million, a decrease of -64.73%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 1, 2026

Data Sources Report a data error